Evidence map›Paper›PMID 39744476›Full record

ArticleJournal of Cancer2025

Hybrid Model with Wavelet Decomposition and EfficientNet for Accurate Skin Cancer Classification.

Amina Aboulmira, Hamid Hrimech, Mohamed Lachgar, Mohamed Hanine, Carlos Osorio Garcia, Gerardo Mendez Mezquita, Imran Ashraf

Abstract read
In one paragraph

Article in Journal of Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amina AboulmiraLAMSAD Laboratory, ENSA, Hassan First University, Berrechid, Morocco.
Hamid HrimechLAMSAD Laboratory, ENSA, Hassan First University, Berrechid, Morocco.
Mohamed LachgarL2IS Laboratory, FSTG, Cadi Ayyad University, Marrakech, Morocco.
Mohamed HanineLTI Laboratory, ENSA, Chouaib Doukkali University, El Jadida, Morocco.
Carlos Osorio GarciaUniversidad Europea del Atlantico, Isabel Torres 21, Santander, 39011, Spain.
Gerardo Mendez MezquitaUniversidad Europea del Atlantico, Isabel Torres 21, Santander, 39011, Spain.
Imran AshrafDepartment of Information and Communication Engineering, Yeungnam University, Gyeongsan, 38541, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Faced with anomalies in medical images, Deep learning is facing major challenges in detecting, diagnosing, and classifying the various pathologies that can be treated via medical imaging. The main challenges encountered are mainly due to the imbalance and variability of the data, as well as its complexity. The detection and classification of skin diseases is one such challenge that researchers are trying to overcome, as these anomalies present great variability in terms of appearance, texture, color, and localization, which sometimes makes them difficult to identify accurately and quickly, particularly by doctors, or by the various Deep Learning techniques on offer. In this study, an innovative and robust hybrid architecture is unveiled, underscoring the symbiotic potential of wavelet decomposition in conjunction with EfficientNet models. This approach integrates wavelet transformations with an EfficientNet backbone and incorporates advanced data augmentation, loss function, and optimization strategies. The model tested on the publicly accessible HAM10000 and ISIC2017 datasets has achieved an accuracy rate of 94.7%, and 92.2% respectively.

Indexed as

convolutional neural networksimage processingskin lesiontransfer learningwavelet decomposition

Identifiers

PMID39744476
PMCPMC11685683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.